Beranda › Sklerosis Multipel › Distrik Columbia › Washington
Uji klinis Sklerosis Multipel di Washington, DC
13 studi untuk Sklerosis Multipel mencari peserta di lokasi sekitar Washington (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
Menerima pesertaFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi jauhnya
Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
Menerima pesertaFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Menerima pesertaStudi observasional
- TG Therapeutics Investigational Trial Site, Washington D.C.
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Menerima pesertaFase 1
- Research Site, Washington D.C.
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Menerima pesertaFase 3
- Georgetown University Hospital, Washington D.C.
- Medstar Washington Hosp Ctr, Washington D.C.
- Mid Atlantic Epilepsy and Sleep Ctr, Bethesda · 7 mi jauhnya
Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy
Menerima pesertaFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Pathological Basis of MRI Signal Changes in Multiple Sclerosis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institutes of Health Clinical Center, Bethesda · 7 mi jauhnya
Genes and Environment in Multiple Sclerosis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- National Institute of Neurological Disorders and Stroke, Bethesda · 7 mi jauhnya
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Menerima pesertaStudi observasional
- Evidera INC., Bethesda · 7 mi jauhnya
- Evidera, Bethesda · 7 mi jauhnya
Uji klinis Sklerosis Multipel di kota lain
- New York City, NY17 studi
- Chicago, IL15 studi
- Boston, MA14 studi
- Cleveland, OH9 studi
- San Francisco, CA8 studi
- Birmingham, AL8 studi
- St. Louis, MO8 studi
- Kansas City, KS8 studi
- Aurora, CO7 studi
- Columbus, OH7 studi
- Baltimore, MD7 studi
- Houston, TX6 studi
Studi lain di Washington
- Kanker (semua jenis)58 studi
- Kanker Paru Non-Sel Kecil55 studi
- Kanker Payudara46 studi
- Kanker Metastatik43 studi
- Kanker Paru41 studi
- Kanker Prostat38 studi
- Obesitas33 studi
- Kanker Kolorektal29 studi
- Penyakit Kardiovaskular28 studi
- Kanker Kandung Kemih26 studi
- Leukemia Mieloid Akut24 studi
- Kanker Ovarium23 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.